Avicenna Journal of Clinical Microbiology and Infection

Published by: Kowsar

Prevalence of Extended Spectrum β-Lactamase in Klebsiella pneumonia Isolates in a Teaching Hospital of Zahedan City, Iran

Authors Information
1 Department of Biology, Faculty of Basic Sciences, University of Zabol, Zabol, IR Iran
2 Department of Physiopathology, Faculty of Veterinary Medicine, University of Zabol, Zabol, IR Iran
3 Departments of Microbiology and Parasitology, Faculty of Medicine, Zabol University of Medical Sciences, Zabol, IR Iran
Article Notes and Dates
Avicenna Journal of Clinical Microbiology and Infection: October 2014, 1 (3); e22934.Published Online: October 19, 2014
Article Type: Research Article; Received : August 20, 2014; Revised : September 10, 2014; Accepted : September 16, 2014
DOI: http://dx.doi.org/10.17795/ajcmi-22934

To Cite : Barakzahi M, Hormozi B, Rashki A, Rashki Ghalehnoo Z. Prevalence of Extended Spectrum β-Lactamase in Klebsiella pneumonia Isolates in a Teaching Hospital of Zahedan City, Iran, Avicenna J Clin Microb Infec. 2014 ;1(3):e22934. doi: 10.17795/ajcmi-22934.

Copyright: Copyright © 0, Avicenna Journal of Clinical Microbiology and Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Struve C, Krogfelt KA. Pathogenic potential of environmental Klebsiella pneumoniae isolates. Environ Microbiol. 2004; 6(6): 584-90[DOI][PubMed]
  • 2. Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, et al. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol. 2007; 45(10): 3352-9[DOI][PubMed]
  • 3. Hu DL, Maina EK, Omoe K, Inoue F, Yasujima M, Nakane A. Superantigenic toxin genes coexist with specific staphylococcal cassette chromosome mec genes in methicillin-resistant Staphylococcus aureus. Tohoku J Exp Med. 2011; 225(3): 161-9[PubMed]
  • 4. Medeiros AA. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis. 1997; 24 Suppl 1-45[PubMed]
  • 5. Mirzaee M, Pourmand MR, Chitsaz M, Mansouri S. Antibiotic Resistance to Third Generation Cephalosporins Due to CTX-M-Type Extended-Spectrum ß-Lactamases in Clinical Isolates of Escherichia coli. Iran J Publ Health. 2009; 38(1): 10-7
  • 6. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001; 14(4): 933-51[DOI][PubMed]
  • 7. Lartigue MF, Zinsius C, Wenger A, Bille J, Poirel L, Nordmann P. Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother. 2007; 51(8): 2855-60[DOI][PubMed]
  • 8. Ambler RP, Coulson AF, Frere JM, Ghuysen JM, Joris B, Forsman M, et al. A standard numbering scheme for the class A beta-lactamases. Biochem J. 1991; 276 ( Pt 1): 269-70[PubMed]
  • 9. Kassis-Chikhani N, Saliba F, Carbonne A, Neuville S, Decre D, Sengelin C, et al. Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004. Euro Surveill. 2010; 15(46)[PubMed]
  • 10. Borer A, Gilad J, Menashe G, Peled N, Riesenberg K, Schlaeffer F. Extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel. Med Sci Monit. 2002; 8(1)-7[PubMed]
  • 11. Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis. 2009; 49(5): 682-90[DOI][PubMed]
  • 12. Cockerill FR, Patel JB, Adler J, Bradford PA, Dudley MN, Eliopoulos GM. Performance standards for antimicrobial susceptibility testing;Twenty- Third informational supplement. 2013;
  • 13. Fang H, Ataker F, Hedin G, Dornbusch K. Molecular epidemiology of extended-spectrum beta-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol. 2008; 46(2): 707-12[DOI][PubMed]
  • 14. Babypadmini S, Appalaraju B. Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol. 2004; 22(3): 172-4[PubMed]
  • 15. Bajpai T, Pandey M, Varma M, Bhatambare GS. Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: Implications on empiric therapy. Indian J Pathol Microbiol. 2014; 57(3): 407-12[DOI][PubMed]
  • 16. Kargar M, Kargar M, Jahromi MZ, Najafi A, Ghorbani-Dalini S. Molecular detection of ESBLs production and antibiotic resistance patterns in Gram negative bacilli isolated from urinary tract infections. Indian J Pathol Microbiol. 2014; 57(2): 244-8[DOI][PubMed]
  • 17. Moayednia R, Shokri D, Mobasherizadeh S, Baradaran A, Fatemi SM, Merrikhi A. Frequency assessment of beta-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection. J Res Med Sci. 2014; 19-5[PubMed]
  • 18. Koren M, Demons S, Murray C, Mahlen S, Schofield C. Characterization of infections with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella species at a major military medical center. Mil Med. 2014; 179(7): 787-92[DOI][PubMed]
  • 19. Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect. 2008; 14 Suppl 1: 159-65[DOI][PubMed]
  • 20. Patzer JA, Dzierzanowska D, Pawinska A, Turner PJ. High activity of meropenem against Gram-negative bacteria from a paediatric Intensive Care Unit, 2001-2005. Int J Antimicrob Agents. 2007; 29(3): 285-8[DOI][PubMed]
  • 21. Patzer JA, Dzierzanowska D. Increase of imipenem resistance among Pseudomonas aeruginosa isolates from a Polish paediatric hospital (1993-2002). Int J Antimicrob Agents. 2007; 29(2): 153-8[DOI][PubMed]
  • 22. Sirot DL, Goldstein FW, Soussy CJ, Courtieu AL, Husson MO, Lemozy J, et al. Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother. 1992; 36(8): 1677-81[PubMed]
  • 23. Leseva M, Arguirova M, Nashev D, Zamfirova E, Hadzhyiski O. Nosocomial infections in burn patients: etiology, antimicrobial resistance, means to control. Ann Burns Fire Disasters. 2013; 26(1): 5-11[PubMed]
  • 24. Khorshidi A, Rohani M, Moniri R. The prevalence and molecular characterization of extended-spectrum β-lactamases-producing Klebsiella pneumoniae isolates recovered from Kashan hospital university, Iran. Jundishapur J Microbiol. 2012; 4(4): 289-94
  • 25. Mehrgan H, Rahbar M, Arab-Halvaii Z. High prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran. J Infect Dev Ctries. 2010; 4(3): 132-8[PubMed]
  • 26. Mobaleghi J, Salimizand H, Beiranvand S, Membari S, Kalantar E. Extended spectrtrum B-lactamase in urinary isolates of Escheichia coli in five iranian hospitals. Asian J Pharm Clin Res. 2011; 5(2): 35-6
  • 27. Velez Echeverri C, Serna-Higuita LM, Serrano AK, Ochoa-Garcia C, Rojas Rosas L, Maria Bedoya A, et al. Resistance profile for pathogens causing urinary tract infection in a pediatric population, and antibiotic treatment response at a university hospital, 2010-2011. Colomb Med (Cali). 2014; 45(1): 39-44[PubMed]
  • 28. Ghafourian S, Bin Sekawi Z, Sadeghifard N, Mohebi R, Kumari Neela V, Maleki A, et al. The Prevalence of ESBLs Producing Klebsiella pneumoniae Isolates in Some Major Hospitals, Iran. Open Microbiol J. 2011; 5: 91-5[DOI][PubMed]
  • 29. Aminzadeh Z, Sadat Kashi M, Sha'bani M. Bacteriuria by extended-spectrum Beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: isolates in a governmental hospital in South of Tehran, Iran. Iran J Kidney Dis. 2008; 2(4): 197-200[PubMed]
  • 30. Messai Y, Benhassine T, Naim M, Paul G, Bakour R. Prevalence of beta-lactams resistance among Escherichia coli clinical isolates from a hospital in Algiers. Rev Esp Quimioter. 2006; 19(2): 144-51[PubMed]
  • 31. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, et al. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis. 2005; 40(9): 1317-24[DOI][PubMed]
  • 32. Moland ES, Hanson ND, Black JA, Hossain A, Song W, Thomson KS. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002. J Clin Microbiol. 2006; 44(9): 3318-24[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By:

Search Relations:


  • Mahbobeh Barakzahi: [PubMed] [Scholar]
  • Bahman Hormozi: [PubMed] [Scholar]
  • Ahmad Rashki: [PubMed] [Scholar]
  • Zahra Rashki Ghalehnoo: [PubMed] [Scholar]
  • Related Article in PubMed
  • Related Article in Google Scholar

Create Citiaion Alert via Google Reader